MA Provider

What MA Provider does

MA Provider is an Italian healthcare consulting firm founded in 2010 by Elena Paola Lanati (formerly a Business Unit Director at Procter & Gamble, AstraZeneca, UCB Pharma, Bristol Myers Squibb, and Amgen), headquartered in Milano with additional offices in Roma. The company specializes exclusively in market access for pharmaceutical and medical-technology products within the Italian National Health Service (SSN/SSR), covering the full access lifecycle: national access strategy, AIFA pricing and reimbursement negotiation, regional implementation, public affairs, health economics, HTA, and Real World Evidence (RWE) studies.

The company's core offerings are organized into two service lines — Consulenza (strategic advisory) and Execution (implementation of access plans) — supported by proprietary assets including the MAP (Market Access Plan) web-based planning tool with configurable stakeholder, scorecard, and National Drug Code modules; the SCAN integrated access system developed for the Lombardy Region FIMSER tender; and ISO 27001-certified RWE methodology for clinical and administrative database analyses. Adjacent programs include the Market Access Academy (executive training launched 2012 with 20+ big-pharma participants), the annual Workshop on Drug Pricing (since 2015), the Market Access Award (since 2015, co-organized with Università del Piemonte Orientale), and the ATMP Forum (since 2017) focused on Advanced Therapy Medicinal Products.

MA Provider operates as a private limited company (MA Provider srl) under the direction and coordination of AmerisourceBergen B.V. (now Cencora). It serves a mix of enterprise pharmaceutical clients (named logos include Roche Italia, Takeda Italia, AbbVie, Pfizer Italia, Biogen Idec, and Novartis), Italian healthcare institutions and regional authorities (Lombardy, Lazio, Campania), and patient associations. Revenue is generated through professional-services consulting engagements, training course fees (EUR 450–1500+VAT), and event registrations (EUR 200–1500). The team is described as "constantly growing" past 30 people, with recent leadership additions including Managing Director Fulvio Luccini (ex-Novartis, October 2020) and ongoing international expansion following a 2019 organizational restructure.

Name

MA Provider

Legal name

MA Provider srl

Website

https://maprovider.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

MA Provider is an Italian healthcare consulting firm founded in 2010 that provides end-to-end market access services to pharmaceutical companies, healthcare institutions, and patient associations operating within the Italian National Health Service, covering AIFA negotiation, regional access strategy, RWE studies, and executive training.

Ownership category

akta.pro rank

Headquarters

HQ city

Milano

HQ country

Italy

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others, Technology or R&D

Revenue model

1. Consultancy Services: Consulting services for pharmaceutical companies covering market access strategy, national and regional access negotiation with AIFA, public affairs, health economics, HTA, and RWE. Services can cover entire access process or specific phases.
2. RWE Studies: Design and implementation of Real World Evidence studies for rare and common diseases, including epidemiology, PDTA, pharmaceutical product use analysis, and burden of disease studies.
3. Training - Market Access Academy: Executive courses for healthcare professionals on market access tools and drug value management in the Italian NHS context. Course fees range from 450 EUR to 1500 EUR plus VAT, with discounts for multiple registrations.
4. Events and Workshops: Workshop on Drug Pricing annual event with registration fees ranging from 200 EUR (early, without hospitality) to 1500 EUR (standard, with hospitality) for pharmaceutical company employees.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

MA Provider is a healthcare consulting firm that supports pharmaceutical companies (from startups to big pharma) and healthcare institutions with end-to-end market access services in Italy. Core offerings include strategic advisory on AIFA pricing and reimbursement negotiations, national and regional access strategy, public affairs, health economics, HTA, and the design and execution of Real World Evidence (RWE) studies. Supporting offerings include the Market Access Academy training program and the proprietary MAP web-based tool for monitoring access plans.

Product overview

MA Provider is a healthcare consulting company established in 2010, specializing exclusively in market access for pharmaceutical and medical technologies in Italy. The company operates two core service lines: Consulenza (Consultancy) for strategic advisory on pricing negotiations with AIFA and national/regional access strategies, and Execution for implementing market access plans. Supporting services include RWE Studies for real-world evidence generation, Market Access Academy for professional training (established 2012), and the Market Access Plan (MAP) web-based tool for monitoring access activities. The company also runs educational programs including the Workshop on Drug Pricing (since 2015) and Market Access Award (since 2015). Specialty focus areas include ATMPs (Advanced Therapy Medicinal Products), HCV/hepatitis initiatives, and rare disease market access.

Differentiator

Problem solved

Functional benefit

Brands

• Market Access Academy: Executive training program for healthcare professionals in market access, launched 2012
• RWE Studies
• Market Access Award
• Workshop on Drug Pricing
• Market Access Plan (MAP)
• ATMP Forum

Products and services

• Consulenza (Consultancy)
• Execution
• RWE Studies (Real World Evidence)
• Market Access Academy
• Workshop on Drug Pricing
• Market Access Award

Quantifiable outcome

• Successfully supported pharmaceutical companies through AIFA pricing renegotiations resulting in smooth processes and successful outcomes
• +1 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• Università del Piemonte OrientalecoreStrategic or Co-development Partner · 1 April 2015Academic partner for the Workshop on Drug Pricing (annual since 2015) and Market Access Award. The partnership involves scientific board collaboration with professors Pier Luigi Canonico, Armando Genazzani, and Claudio Jommi.
• ISPOR Italy-Rome ChaptercoreStrategic or Co-development Partner · 1 January 2014Founded by Elena Paola Lanati in 2014. MA Provider serves as the secretariat for this chapter of the International Society for Pharmacoeconomics and Outcomes Research. Hosts annual national conferences.
• Amerisourcebergen B.V. (now Cencora)coreOthersParent company exercising management and coordination over MA Provider. MA Provider became part of Amerisourcebergen (now Cencora), a global pharmaceutical sourcing and distribution company, providing strategic alignment and corporate backing.
• ATMP ForumcoreStrategic or Co-development PartnerMA Provider leads the ATMP Forum, launched in 2017 as Italy's first project addressing advanced therapy medicinal products comprehensively. Promotes interaction between institutions, clinicians, researchers, and payers. Produces annual ATMP reports for Italy.
• AIFA - Agenzia Italiana del FarmacocoreOthersPrimary regulatory authority for pharmaceutical market access in Italy. MA Provider works closely with AIFA on pricing and reimbursement negotiations, access strategies, and regulatory dossier preparation.
• CittadinanzAttivacoreStrategic or Co-development PartnerPatient advocacy organization that co-sponsors the Market Access Award. Integral part of the expert panel evaluating partnership projects between pharma companies and public institutions.
• Istituto Superiore di Sanità (ISS)coreOthersNational health institute that co-sponsors the Market Access Award and participates in MA Provider-organized events and initiatives on advanced therapies and rare diseases.
• Alleanza contro l'Epatite (ACE)minorStrategic or Co-development PartnerAlliance against hepatitis in which MA Provider participates, working with AISF, SIMIT, and EpaC Onlus on HCV screening and treatment advocacy in Italy.
• SDA Bocconi School of ManagementminorStrategic or Co-development PartnerAcademic partner, notably in the Market Access Award 2015 project with Biogen Idec. Professor Claudio Jommi serves as a scientific board member for multiple MA Provider events.
• Clinical and Administrative Database NetworkscoreTechnology or IntegrationMA Provider accesses Italian clinical and administrative databases for RWE studies, epidemiology, and burden of disease analyses, enabling real-world evidence generation for pharmaceutical clients.
• Regione LombardiaminorOthersWon the Lombardia Region's FIMSER Call for tenders with the Pricing project (SCAN), leading to the founding of MA Provider.
• Regione CampaniaminorOthersRegional government partner in HCV patient access initiatives and other healthcare access projects.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Health Advances: Healthcare strategy consulting firm advising medtech, biopharma, and diagnostics clients on commercial, pricing, and market access strategy. Comparable because it serves similar pharma clients with similar evidence-and-pricing-led engagements.
• BresMed: Health economics and market access consultancy serving pharma and medtech. Comparable because it competes in HTA submissions, economic modeling, and market access support across European markets.
• Alira Health: Global healthcare consulting and advisory firm covering market access, real-world evidence, and patient-centric strategy for pharma. Comparable because it directly competes in EU market access and RWE services for life sciences clients.
• Simon-Kucher & Partners: Global consultancy specializing in pricing, reimbursement, and market access strategy for pharma and medtech. Comparable because its life sciences practice directly competes for AIFA negotiation and pricing strategy mandates similar to MA Provider's.
• Putnam Associates: Pharma strategy consultancy focused on market access, pricing, and commercial strategy. Comparable because it serves global pharma clients on European market access challenges analogous to MA Provider's Italian practice.
• Charles River Associates (CRA Life Sciences): Life sciences consulting practice focused on pricing, market access, and evidence-based strategy for pharma. Comparable because it competes for HTA, pricing, and value strategy engagements in European pharma markets.
• Locust Walk: Biopharma advisory and consulting firm covering market access, commercial strategy, and transactions. Comparable because it advises pharma clients on European and global market access strategy analogous to MA Provider's offering.

Broad incumbents

• Cencora (formerly AmerisourceBergen): Global pharmaceutical sourcing and distribution company exercising corporate coordination over MA Provider. Comparable as both parent and ecosystem player distributing the same pharma products whose market access MA Provider supports.
• IQVIA: Global life sciences and market access services giant. Comparable because it offers end-to-end market access, HTA, pricing, and RWE consulting for pharmaceutical companies across major European markets including Italy.
• PharmaLex (Pharmalex): Global pharma regulatory and market access services provider, which appears as a parent-level entity for MA Provider in some sources. Comparable because it offers regulatory affairs and market access consulting to pharma across multiple geographies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/MAProvider
• Facebookfacebook.com/maprovider
• LinkedInlinkedin.com/company/maprovider-srl
• Instagraminstagram.com/maprovider

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MA Provider